查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1798957

全球醫療微晶片市場

Microchips in Medicine
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 285 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球醫療微晶片市場規模將達到 27 億美元

全球醫療保健微晶片市場規模預計在2024年為15億美元，到2030年將達到27億美元，2024年至2030年的複合年成長率為10.8%。藥物輸送應用是本報告分析的細分市場之一，預計其複合年成長率將達到12.2%，到分析期結束時市場規模將達到18億美元。家庭監控應用細分市場在分析期間內的複合年成長率預計為8.1%。

美國市場規模估計為 4.013 億美元，中國市場預計複合年成長率為 14.9%

預計到2024年，美國醫療微晶片市場規模將達到4.013億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到5.691億美元，在2024-2030年的分析期間內，複合年成長率為14.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.7%和9.6%。在歐洲，預計德國市場的複合年成長率約為8.6%。

全球醫療微晶片市場－主要趨勢與促進因素摘要

微晶片將如何改變未來的醫療診斷和治療方法？

醫療晶片（也稱為植入式或可攝取式醫療晶片）正在重新定義醫療專業人員診斷、監測和治療各種健康狀況的方式。這些基於半導體的設備通常只有米粒大小或更小，用於監測生命徵象、將藥物輸送到目標位置，或確保患者遵醫囑服藥。嵌入藥丸中的可攝取式感測器晶片可在服藥後傳輸數據，提供藥物攝入的即時回饋；而植入式晶片則透過長期生物訊號追蹤來監測心血管疾病、癲癇和糖尿病等慢性疾病。

這些晶片融合了生物相容性材料、電子機械系統 (MEMS)、低功耗半導體和無線資料傳輸技術。與需要醫生上門或使用笨重設備的傳統監測技術不同，微晶片能夠提供持續、被動和遠端的健康監測。隨著全球醫療保健向個人化醫療轉型，這些晶片使醫生能夠根據即時收集的患者特定數據量身定做治療方法。

哪些技術突破將推動微晶片在醫療保健領域的應用？

材料科學、奈米製造和微流體的關鍵創新正在推動微晶片在醫療保健領域的部署。如今，晶片配備了生物感測器，可以檢測pH值、血糖濃度、電解質和酶活性等生化訊號。電源效率顯著提升，晶片僅需使用小型電池或能源採集機制（例如壓電和熱電系統）即可運作數月甚至數年。超低功耗積體電路 (IC) 和無線晶片系統(SoC) 實現了向智慧型手機和雲端平台的無縫資料傳輸。

最有前景的領域之一是智慧藥物傳輸系統，該系統中的晶片經過預先編程，可在生物觸發或遠端控制下釋放藥物。該系統已在癌症治療和荷爾蒙治療的臨床前試驗中得到檢驗。嵌入心律調節器和神經刺激設備的微晶片可以連續傳輸心律和神經活動數據。最近的趨勢還包括皮下植入晶片和電子紋身，它們可以非侵入性地追蹤水分、體溫和電生理訊號。

此外，隨著基於區塊鏈的安全資料傳輸和人工智慧主導的分析技術的發展，晶片產生的數據正逐漸實用化預測性診斷和人口健康管理。 FDA 等監管機構正在認可此類晶片的安全性和效用，從而加速其臨床應用。

哪個醫療領域採用微晶片技術的比例最高？

慢性病管理是最重要的應用領域之一。例如，糖尿病患者受益於配備微晶片的連續血糖監測儀 (CGM)，該監測儀能夠不間斷地將資料傳輸到胰島素幫浦和醫療保健提供者。在心臟科領域，心律調節器和去心房顫動中的植入式晶片可用於追蹤心律不整、心率變異性和心臟衰竭的早期徵兆。神經系統應用包括即時監測癲癇發作、顱內壓和脊髓活動的晶片。

在製藥領域，可攝取微晶片正被納入臨床實驗和依從性監測。 Proteus Digital Health 是該領域的先驅，推出了一款可指示服藥成功的藥丸，用於驗證思覺失調症。在整形外科和關節置換領域，晶片被嵌入植入中，用於監測癒合率、負荷動態和感染指標。

獸醫學是另一個平行成長的領域，其中RFID微晶片用於牲畜和寵物的追蹤、診斷和疫苗監測。從地理位置來看，北美在研發、臨床試驗和商業化方面處於領先地位，其次是歐洲，歐洲對病患資料法規和公共衛生整合有著濃厚的興趣。由於政府在數位健康基礎設施和半導體創新方面的努力，亞太地區——特別是中國、日本和韓國——正在迅速崛起。

是什麼推動了全球醫療微晶片市場的成長？

全球醫療保健微晶片市場的成長受到多種因素的推動，包括慢性病負擔的加重、醫療保健服務向以患者為中心的轉變，以及遠端監控技術的日益普及。即時和連續診斷的需求促使醫療保健系統將微晶片納入主流治療途徑。感測器和晶片的微型化和低價格降低了進入門檻，使其能夠在住院和門診環境中廣泛部署。

智慧型手機、穿戴式裝置和物聯網平台在醫療保健領域的應用日益成長，正在為晶片診斷技術建立數位生態系統。新冠疫情加速了遠距遠端醫療的普及，並凸顯了非接觸式監測的需求。製藥公司擴大將晶片嵌入口服藥物中，以提高患者用藥依從性，尤其是在精神健康和感染疾病領域。

醫療保健產業向基於結果的報銷和預防性護理的轉變，進一步支持了微晶片提供的持續監測工具。在美國、英國和歐洲部分地區，數位治療和遠距離診斷的報銷代碼正在不斷擴展，從而提升了其商業性可行性。隨著安全架構和惰性材料的應用，資料隱私和生物相容性的擔憂得到解決，微晶片醫療保健的未來將繼續在機構、技術和市場方面獲得發展動力。

部分

用途（藥物傳輸用途、家庭監測用途、其他用途）、最終用途（醫院最終用途、研究最終用途、其他最終用途）

受訪公司範例

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • BioTelemetry（a Philips company）
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies（A Qualcomm Life Company）
  • Cepheid（a Danaher company）
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom（now part of Baxter）
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer（now part of Revvity）
  • Siemens Healthineers
  • Zimmer Biomet

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP39059

Global Microchips in Medicine Market to Reach US$2.7 Billion by 2030

The global market for Microchips in Medicine estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Drug Delivery Application, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Home Monitoring Application segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$401.3 Million While China is Forecast to Grow at 14.9% CAGR

The Microchips in Medicine market in the U.S. is estimated at US$401.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$569.1 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Microchips in Medicine Market - Key Trends & Drivers Summarized

How Are Microchips Transforming the Future of Medical Diagnostics and Therapeutics?

Microchips in medicine-also known as implantable or ingestible medical chips-are redefining how healthcare professionals diagnose, monitor, and treat a wide array of health conditions. These semiconductor-based devices, often the size of a grain of rice or smaller, are being used to monitor vital signs, deliver drugs at targeted locations, or verify patient adherence to prescribed regimens. Ingestible sensor chips embedded in pills can transmit data once ingested, providing real-time feedback on medication intake. Meanwhile, implantable chips monitor chronic diseases such as cardiovascular disorders, epilepsy, or diabetes through long-term biosignal tracking.

These chips represent a fusion of biocompatible materials, micro-electromechanical systems (MEMS), low-power semiconductors, and wireless data transmission. Unlike traditional monitoring techniques that require hospital visits or bulky equipment, microchips offer continuous, passive, and remote health surveillance. As global healthcare pivots toward personalized medicine, these chips enable physicians to adjust treatment regimens based on patient-specific data collected in real time-minimizing adverse drug reactions and maximizing therapeutic efficacy.

What Technological Breakthroughs Are Driving Adoption of Microchips in Healthcare?

Significant innovations in materials science, nanofabrication, and microfluidics are propelling the deployment of microchips in medical settings. Chips now feature biosensors capable of detecting biochemical signals such as pH, glucose levels, electrolytes, or enzyme activity. Power efficiency has been vastly improved, allowing chips to function for months or even years using miniature batteries or energy harvesting mechanisms (e.g., piezoelectric or thermoelectric systems). Ultra-low-power integrated circuits (ICs) and wireless systems-on-chip (SoCs) enable seamless data transmission to smartphones or cloud platforms.

One of the most promising areas is smart drug delivery systems, wherein chips are pre-programmed to release drugs in response to biological triggers or via remote control. This has been validated in preclinical studies for cancer treatment and hormone therapy. Another area of rapid growth is biosignal telemetry, where microchips embedded in pacemakers or neurostimulators relay continuous data on heart rhythms or neural activity. Recent developments also include skin-interfaced microchips and electronic tattoos capable of non-invasively tracking hydration, temperature, and electrophysiological signals.

Furthermore, blockchain-based secure data transmission and AI-driven analytics are making chip-generated data actionable in predictive diagnostics and population health management. Regulatory bodies such as the FDA are increasingly acknowledging the safety and utility of such chips, thereby accelerating clinical adoption.

Which Medical Fields Are Seeing the Highest Adoption Rates of Microchip Technologies?

Chronic disease management is among the most significant application areas. Diabetic patients, for instance, benefit from continuous glucose monitors (CGMs) equipped with microchips, enabling non-stop data relay to insulin pumps or healthcare providers. In cardiology, implantable chips inside pacemakers or defibrillators are used to track arrhythmias, heart rate variability, and early signs of heart failure. Neurological applications include chips that monitor seizures, intracranial pressure, or spinal cord activity in real time.

The pharmaceutical sector is integrating ingestible microchips into drug trials and compliance monitoring. Proteus Digital Health pioneered this segment, launching a pill that signals successful ingestion-a feature being utilized to verify adherence in schizophrenia and hepatitis C treatments. The oncology field is testing microchips for intra-tumoral drug delivery or thermal ablation guidance. In orthopedic and prosthetic applications, chips are being embedded in implants to monitor healing rates, load dynamics, and infection markers.

Veterinary medicine is another parallel growth segment where RFID microchips are used for tracking, diagnostics, and vaccine monitoring in livestock and pets. Geographically, North America leads in R&D, clinical trials, and commercialization, followed by Europe with a strong focus on patient data regulation and public health integration. Asia-Pacific-particularly China, Japan, and South Korea-is emerging rapidly due to government initiatives in digital health infrastructure and semiconductor innovation.

What Is Fueling Growth in the Global Microchips in Medicine Market?

The growth in the global microchips in medicine market is driven by several factors, including the rising burden of chronic diseases, a shift toward patient-centric healthcare delivery, and increased adoption of remote monitoring technologies. The demand for real-time, continuous diagnostics has prompted healthcare systems to integrate microchips into mainstream treatment pathways. Miniaturization and affordability of sensors and chips are reducing entry barriers, enabling broader deployment across both inpatient and outpatient settings.

A parallel rise in the use of smartphones, wearables, and IoT platforms in healthcare is creating a supportive digital ecosystem for chip-enabled diagnostics. The COVID-19 pandemic accelerated telehealth acceptance and highlighted the need for contactless monitoring-reinforcing the value of ingestible or implantable microchips. Pharmaceutical companies are increasingly embedding chips in oral formulations to improve drug compliance, especially in mental health and infectious disease segments.

The healthcare sector’s movement toward outcome-based reimbursement and preventative care further incentivizes continuous monitoring tools that microchips offer. Reimbursement codes for digital therapeutics and remote diagnostics are expanding across the US, UK, and parts of Europe, bolstering commercial viability. As concerns over data privacy and biocompatibility are addressed through secure architectures and inert materials, the microchip-enabled healthcare future continues to gain institutional, technological, and market momentum.

SCOPE OF STUDY:

The report analyzes the Microchips in Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Delivery Application, Home Monitoring Application, Other Applications); End-Use (Hospitals End-Use, Research Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • BioTelemetry (a Philips company)
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies (A Qualcomm Life Company)
  • Cepheid (a Danaher company)
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom (now part of Baxter)
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer (now part of Revvity)
  • Siemens Healthineers
  • Zimmer Biomet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Microchips in Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Development of Smart Pills and Ingestible Microchips Throws the Spotlight on Digital Medicine
    • Rising Need for Continuous Patient Monitoring Drives Adoption of Implantable Microchips
    • Advances in Biocompatible Semiconductor Materials Enhance Medical Integration of Microchips
    • Growth in Remote Patient Management Solutions Spurs Demand for Chip-Enabled Wearable Devices
    • Use of Microchips for Drug Release Timing Enhances Precision Therapy Protocols
    • Surge in Interest in Digital Biomarkers Expands Use of Embedded Chips for Vital Sign Capture
    • Integration of NFC and RFID Technologies Drives Development of Smart Packaging in Pharma
    • Expansion of Electronic Health Monitoring Systems Strengthens Business Case for Chip-Enabled Devices
    • Innovation in Energy Harvesting and Wireless Charging Enhances Microchip Usability in Medicine
    • Growing Investment in Neurotechnology Spurs Development of Brain-Implanted Monitoring Chips
    • Advances in Lab-on-Chip Diagnostics Drive Miniaturized Point-of-Care Testing Applications
    • Regulatory Approvals for Ingestible Sensors Expand Commercialization of Diagnostic Microchips
    • Collaborations with Pharma Firms Accelerate Development of Companion Diagnostics Using Chips
    • Increase in Clinical Trials Using Sensor-Based Monitoring Enhances Microchip Market Penetration
    • Focus on AI Integration Within Chipsets Supports Personalized and Predictive Healthcare
    • Growth in Geriatric Care Needs Propels Use of Monitoring Chips in Long-Term Care Settings
    • Use of Blockchain and Smart Contracts in Chip-Enabled Drug Traceability Strengthens Compliance
    • Expansion of Telehealth Infrastructure Globally Spurs Use of Chip-Based Mobile Health Devices
    • Development of Closed-Loop Drug Delivery Systems Integrates Microchips for Feedback Control
    • Public Acceptance of Biometric Implants Opens Pathways for Wider Use of Microchips in Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microchips in Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Delivery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Home Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION